Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis
- PMID: 33818231
- PMCID: PMC8023604
- DOI: 10.1080/07853890.2021.1906943
Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis
Abstract
Objective: This study aimed to assess the diagnostic accuracy of serum LDH to pleural ADA ratio (cancer ratio, CR)for malignant pleural effusion (MPE) through an original study and meta-analysis.
Methods: We retrospectively collected data from 145 patients with MPE and 117 cases of benign pleural effusions (BPE). The diagnostic performance of CR and a typical biomarker of MPE, carcinoembryonic antigen (CEA), were analysed using the receiver operating characteristic (ROC) curves and the area under the curve (AUC) as a measure of accuracy. The overall diagnostic accuracy of CR was summarised by a standard diagnostic meta-analysis.
Results: Significantly higher CR and pleural CEA values were observed in the MPE patients than in the BPE patients. At a cut-off value of 14.97, CR showed high sensitivity (0.91), low specificity (0.67), and high AUC (0.85). The combination of CEA and CR increased the AUC to 0.98. The meta-analysis included seven studies involving 2,078 patients. The pooled values for sensitivity, specificity, positive/negative likelihood ratio, and diagnostic odds ratio of CR were 0.96, 0.88, 7.70, 0.05, and 169, respectively. The AUC of the summary ROC of CR was 0.98.
Conclusion: CR has a high diagnostic accuracy for predicting MPE, especially when used in combination with pleural CEA.
Keywords: Malignant pleural effusion; cancer ratio; carcinoembryonic antigen; diagnosis; meta-analysis.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures






Similar articles
-
Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.Pathol Oncol Res. 2022 Apr 20;28:1610280. doi: 10.3389/pore.2022.1610280. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35515016 Free PMC article.
-
Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.Int J Clin Oncol. 2017 Apr;22(2):283-290. doi: 10.1007/s10147-016-1073-y. Epub 2016 Dec 18. Int J Clin Oncol. 2017. PMID: 27990560
-
Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.Postgrad Med. 2015 Jun;127(5):529-34. doi: 10.1080/00325481.2015.1048180. Epub 2015 May 15. Postgrad Med. 2015. PMID: 25979108
-
Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis.Respirology. 2008 Jun;13(4):518-27. doi: 10.1111/j.1440-1843.2008.01291.x. Epub 2008 Apr 14. Respirology. 2008. PMID: 18422869
-
Diagnostic value of survivin for malignant pleural effusion: a clinical study and meta-analysis.Int J Clin Exp Pathol. 2014 Aug 15;7(9):5880-7. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25337230 Free PMC article. Review.
Cited by
-
A Case of Pneumonia Masking Pleural Malignancy.Onco Targets Ther. 2022 Jul 2;15:741-746. doi: 10.2147/OTT.S366221. eCollection 2022. Onco Targets Ther. 2022. PMID: 35813309 Free PMC article.
-
Diagnostic value of periostin in lung cancer-related malignant pleural effusion.J Clin Lab Anal. 2022 Feb;36(2):e24179. doi: 10.1002/jcla.24179. Epub 2021 Dec 27. J Clin Lab Anal. 2022. PMID: 35152510 Free PMC article.
-
LDH/ADA ratio in pleural fluid for the diagnosis of infectious pleurisy.Clin Exp Med. 2023 Dec;23(8):5201-5213. doi: 10.1007/s10238-023-01194-y. Epub 2023 Sep 25. Clin Exp Med. 2023. PMID: 37747590
-
Age affects the diagnostic accuracy of the cancer ratio for malignant pleural effusion.BMC Pulm Med. 2023 Jun 7;23(1):198. doi: 10.1186/s12890-023-02475-8. BMC Pulm Med. 2023. PMID: 37286973 Free PMC article.
-
Adenosine deaminase-based measurement in the differential diagnosis of pleural effusion: a multicenter retrospective study.Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231155747. doi: 10.1177/17534666231155747. Ther Adv Respir Dis. 2023. PMID: 36846945 Free PMC article.
References
-
- Meriggi F. Malignant pleural effusion: still a long way to go. Rev Recent Clin Trials. 2019; 14(1):24–30. - PubMed
-
- Thomas JM, Musani AI.. Malignant pleural effusions: a review. Clin Chest Med. 2013;34(3):459–471. - PubMed
-
- Egan AM, McPhillips D, Sarkar S, et al. . Malignant pleural effusion. QJM. 2014;107(3):179–184. - PubMed
-
- Montero-Arias F, Cartin-Ceba R, Rojas-Solano J, et al. . Pleural effusion size as prognostic marker in patients with malignant pleural effusion. Pleura. 2015;2:237399751560065.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials